Select Medical (SEM) SVP surrenders shares to cover taxes

Rhea-AI Filing Summary

Select Medical Holdings Corp senior vice president Robert G. Breighner Jr. reported a tax-related share disposition. On the vesting of restricted stock, he surrendered 1,330 shares of common stock to satisfy his tax withholding obligation at $16.44 per share. After this non-market transaction, he directly holds 34,696 shares of Select Medical common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Breighner Robert G. JR

Role SENIOR VICE PRESIDENT

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	1,330	$16.44	$22K

Holdings After Transaction: Common Stock — 34,696 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares surrendered: 1,330 shares Disposition price: $16.44 per share Shares held after transaction: 34,696 shares

3 metrics

Shares surrendered 1,330 shares Tax-withholding disposition on restricted stock vesting

Disposition price $16.44 per share Value used for tax-withholding surrender

Shares held after transaction 34,696 shares Direct ownership following tax-withholding event

Key Terms

restricted stock, tax withholding obligation, tax-withholding disposition

3 terms

restricted stock financial

"incident to vesting of restricted stock."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

tax withholding obligation financial

"to satisfy tax withholding obligation incident to vesting"

tax-withholding disposition financial

"transaction_action: tax-withholding disposition"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Breighner Robert G. JR

(Last) (First) (Middle)

C/O SELECT MEDICAL HOLDINGS CORPORATION

4714 GETTYSBURG ROAD

(Street)

MECHANICSBURG PENNSYLVANIA 17055

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SELECT MEDICAL HOLDINGS CORP [ SEM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SENIOR VICE PRESIDENT

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/04/2026		F(1)		1,330	D	$16.44	34,696	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Surrender of shares to satisfy tax withholding obligation incident to vesting of restricted stock.

	/s/ John F. Duggan, Attorney-in-Fact	05/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Select Medical (SEM) report for Robert G. Breighner Jr.?

Robert G. Breighner Jr., a senior vice president at Select Medical, reported surrendering 1,330 shares of common stock. The shares were delivered to cover tax withholding owed when restricted stock vested, rather than sold on the open market.

Was the Select Medical (SEM) Form 4 transaction an open-market sale?

No, the Form 4 describes a tax-withholding disposition, not an open-market sale. Shares were surrendered back to satisfy a tax obligation triggered by the vesting of restricted stock, according to the filing’s footnote.

How many Select Medical (SEM) shares did Robert G. Breighner Jr. surrender?

He surrendered 1,330 shares of Select Medical common stock. The disposition price reported was $16.44 per share, and the transaction was classified as a tax-withholding event linked to restricted stock vesting.

How many Select Medical (SEM) shares does Robert G. Breighner Jr. hold after this Form 4?

Following the tax-withholding disposition, Robert G. Breighner Jr. directly holds 34,696 shares of Select Medical common stock. This post-transaction figure reflects his remaining direct ownership after surrendering shares to cover tax obligations.

What does the tax-withholding code F mean in the Select Medical (SEM) Form 4?

Code F indicates shares were delivered to pay the exercise price or related taxes, not sold for investment reasons. In this case, 1,330 shares were surrendered to satisfy tax withholding when restricted stock vested for the executive.